FDA Application
-
NDC Search Results on Active Ingredient: fluticasone propionate
Click on Active Ingredient to view the label.
| Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
|---|---|---|---|---|---|
| FLUTICASONE PROPIONATE | 69306-016-01 | Doc Rx | ANDA077570 | HUMAN PRESCRIPTION DRUG | ANDA |
| FLUTICASONE PROPIONATE | 55910-773-01 | Dolgencorp Inc | ANDA207957 | HUMAN OTC DRUG | ANDA |
| FLUTICASONE PROPIONATE | 55910-773-02 | Dolgencorp Inc | ANDA207957 | HUMAN OTC DRUG | ANDA |
| FLUTICASONE PROPIONATE | 55910-607-02 | Dolgencorp, LLC | ANDA207957 | HUMAN OTC DRUG | ANDA |
| FLUTICASONE PROPIONATE | 0168-0332-60 | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | ANDA076451 | HUMAN PRESCRIPTION DRUG | ANDA |
| FLUTICASONE PROPIONATE | 0168-0332-15 | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | ANDA076451 | HUMAN PRESCRIPTION DRUG | ANDA |
| FLUTICASONE PROPIONATE | 0168-0332-30 | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | ANDA076451 | HUMAN PRESCRIPTION DRUG | ANDA |
| FLUTICASONE PROPIONATE | 81522-005-02 | FSA Store Inc. | ANDA207957 | HUMAN OTC DRUG | ANDA |
| FLUTICASONE PROPIONATE | 81522-002-08 | FSA Store Inc. | ANDA207957 | HUMAN OTC DRUG | ANDA |
| FLUTICASONE PROPIONATE | 81522-073-34 | FSA Store Inc. (Caring Mills) | ANDA208024 | HUMAN OTC DRUG | ANDA |
| SALMETEROL XINAFOATE; FLUTICASONE PROPIONATE | 0173-0717-20 | GlaxoSmithKline LLC | NDA021254 | HUMAN PRESCRIPTION DRUG | NDA |
| SALMETEROL XINAFOATE; FLUTICASONE PROPIONATE | 0173-0697-00 | GlaxoSmithKline LLC | NDA021077 | HUMAN PRESCRIPTION DRUG | NDA |
| FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | 0173-0716-22 | GlaxoSmithKline LLC | NDA021254 | HUMAN PRESCRIPTION DRUG | NDA |
| FLUTICASONE PROPIONATE | 0173-0601-02 | GlaxoSmithKline LLC | NDA020833 | HUMAN PRESCRIPTION DRUG | NDA |
| SALMETEROL XINAFOATE; FLUTICASONE PROPIONATE | 0173-0697-04 | GlaxoSmithKline LLC | NDA021077 | HUMAN PRESCRIPTION DRUG | NDA |
| SALMETEROL XINAFOATE; FLUTICASONE PROPIONATE | 0173-0715-20 | GlaxoSmithKline LLC | NDA021254 | HUMAN PRESCRIPTION DRUG | NDA |
| FLUTICASONE PROPIONATE | 0173-0719-20 | GlaxoSmithKline LLC | NDA021433 | HUMAN PRESCRIPTION DRUG | NDA |
| FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | 0173-0716-20 | GlaxoSmithKline LLC | NDA021254 | HUMAN PRESCRIPTION DRUG | NDA |
| SALMETEROL XINAFOATE; FLUTICASONE PROPIONATE | 0173-0717-22 | GlaxoSmithKline LLC | NDA021254 | HUMAN PRESCRIPTION DRUG | NDA |
| FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | 0173-0696-04 | GlaxoSmithKline LLC | NDA021077 | HUMAN PRESCRIPTION DRUG | NDA |
| FLUTICASONE PROPIONATE | 0173-0720-20 | GlaxoSmithKline LLC | NDA021433 | HUMAN PRESCRIPTION DRUG | NDA |
| FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | 0173-0695-04 | GlaxoSmithKline LLC | NDA021077 | HUMAN PRESCRIPTION DRUG | NDA |
| FLUTICASONE PROPIONATE | 0173-0600-02 | GlaxoSmithKline LLC | NDA020833 | HUMAN PRESCRIPTION DRUG | NDA |
| FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | 0173-0696-00 | GlaxoSmithKline LLC | NDA021077 | HUMAN PRESCRIPTION DRUG | NDA |
| FLUTICASONE PROPIONATE | 0173-0718-20 | GlaxoSmithKline LLC | NDA021433 | HUMAN PRESCRIPTION DRUG | NDA |
| FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | 0173-0695-00 | GlaxoSmithKline LLC | NDA021077 | HUMAN PRESCRIPTION DRUG | NDA |
| SALMETEROL XINAFOATE; FLUTICASONE PROPIONATE | 0173-0715-22 | GlaxoSmithKline LLC | NDA021254 | HUMAN PRESCRIPTION DRUG | NDA |
| FLUTICASONE PROPIONATE | 0173-0602-02 | GlaxoSmithKline LLC | NDA020833 | HUMAN PRESCRIPTION DRUG | NDA |
| FLUTICASONE PROPIONATE | 68462-427-02 | Glenmark Pharmaceuticals Inc., USA | ANDA090759 | HUMAN PRESCRIPTION DRUG | ANDA |
| FLUTICASONE PROPIONATE | 60429-195-15 | Golden State Medical Supply, Inc. | ANDA077538 | HUMAN PRESCRIPTION DRUG | ANDA |
| 1-30 | 31-60 | 61-90 | 91-120 | 121-150 | 151-180 | 181-210 | 211-240 | 241-270 | 271-300 |
| 301-330 | 331-360 | 361-390 | 391-420 | 421-426 |
-
